EBR Systems Inc - Asset Resilience Ratio

Latest as of December 2025: 54.70%

EBR Systems Inc (EBR) has an Asset Resilience Ratio of 54.70% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EBR Systems Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$53.22 Million
≈ $37.66 Million USD Cash + Short-term Investments

Total Assets

AU$97.29 Million
≈ $68.84 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how EBR Systems Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is EBR Systems Inc's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down EBR Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore EBR long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$5.79 Million 5.96%
Short-term Investments AU$47.43 Million 48.75%
Total Liquid Assets AU$53.22 Million 54.70%

Asset Resilience Insights

  • Very High Liquidity: EBR Systems Inc maintains exceptional liquid asset reserves at 54.70% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

EBR Systems Inc Industry Peers by Asset Resilience Ratio

Compare EBR Systems Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
Medical Devices 6.28%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Ningbo David Medical Device Co Ltd
SHE:300314
Medical Devices 5.11%
Beijing Succeeder Technology Inc
SHG:688338
Medical Devices 28.27%
Dirui Industrial Co Ltd
SHE:300396
Medical Devices 3.90%
Profound Medical Corp
TO:PRN
Medical Devices 67.66%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for EBR Systems Inc (2019–2025)

The table below shows the annual Asset Resilience Ratio data for EBR Systems Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 54.70% AU$53.22 Million
≈ $37.66 Million
AU$97.29 Million
≈ $68.84 Million
-27.77pp
2024-12-31 82.47% AU$60.66 Million
≈ $42.92 Million
AU$73.56 Million
≈ $52.05 Million
-9.19pp
2023-12-31 91.66% AU$72.32 Million
≈ $51.17 Million
AU$78.90 Million
≈ $55.83 Million
+3.03pp
2022-12-31 88.63% AU$63.53 Million
≈ $44.95 Million
AU$71.68 Million
≈ $50.72 Million
-2.96pp
2021-12-31 91.59% AU$78.24 Million
≈ $55.36 Million
AU$85.42 Million
≈ $60.44 Million
+21.60pp
2020-12-31 69.99% AU$5.88 Million
≈ $4.16 Million
AU$8.40 Million
≈ $5.94 Million
+11.18pp
2019-12-31 58.81% AU$7.29 Million
≈ $5.15 Million
AU$12.39 Million
≈ $8.76 Million
--
pp = percentage points

About EBR Systems Inc

AU:EBR Australia Medical Devices
Market Cap
$82.87 Million
AU$117.11 Million AUD
Market Cap Rank
#20017 Global
#659 in Australia
Share Price
AU$0.26
Change (1 day)
+6.12%
52-Week Range
AU$0.25 - AU$1.47
All Time High
AU$2.01
About

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization thera… Read more